New patent expiration for Sunovion Pharms drug LATUDA
Annual Drug Patent Expirations for LATUDA Latuda is a drug marketed by Sunovion Pharms Inc and is included in one […]
Source
New patent expiration for Sunovion Pharms drug LATUDA Read Post »
Annual Drug Patent Expirations for LATUDA Latuda is a drug marketed by Sunovion Pharms Inc and is included in one […]
Source
New patent expiration for Sunovion Pharms drug LATUDA Read Post »
Annual Drug Patent Expirations for LIVALO Livalo is a drug marketed by Kowa Co and is included in one NDA. […]
Source
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. […]
Source
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
Annual Drug Patent Expirations for PREZCOBIX Prezcobix is a drug marketed by Janssen Prods and is included in one NDA. […]
Source
New patent expiration for Janssen Prods drug PREZCOBIX Read Post »
Annual Drug Patent Expirations for PREZISTA Prezista is a drug marketed by Janssen Prods and is included in two NDAs. […]
Source
New patent expiration for Janssen Prods drug PREZISTA Read Post »
PREZISTA (darunavir) Janssen prods Patent: 8,518,987 Expiration: Aug 16, 2024 See More … For more information on how DrugPatentWatch can […]
Source
Drug Patent Expirations for the Week of August 11, 2024 Read Post »
Annual Drug Patent Expirations for NINLARO Ninlaro is a drug marketed by Takeda Pharms Usa and is included in one […]
Source
New patent expiration for Takeda Pharms drug NINLARO Read Post »
Annual Drug Patent Expirations for OPANA+ER Opana Er is a drug marketed by Endo Pharms and is included in two […]
Source
New patent expiration for Endo Pharms drug OPANA ER Read Post »
OPANA ER (oxymorphone hydrochloride) Endo pharms Patent: 8,114,383 Expiration: Aug 8, 2024 See More … For more information on how […]
Source
Drug Patent Expirations for the Week of August 4, 2024 Read Post »
Annual Drug Patent Expirations for ACUVAIL Acuvail is a drug marketed by Abbvie and is included in one NDA. It […]
Source